News: COVID-19, manufacturing challenges limit cell and gene therapy progress, FDA official says |
Progress in the field of gene and cell therapy continues with rapid development despite the negative impact of COVID-19 on research into novel treatments, according to the director of FDA’s Center for Biologics Evaluation and Research. Peter Marks, MD, PhD, delivered this assessment during the virtual Cell & Gene Meeting on the Mesa. Read more... |
Conference: 4th Annual Genome Editing US Congress |
Bringing together leading omics experts from around the world and comprised of three outstanding programmes, delegates can expect to benefit from critical discussions and case studies shaping the future of Next Generation Sequencing, Multi-omic Single Cell Analysis (including spatial transcriptomics) and Genome Editing in Drug Discovery & Therapeutic Development, December 3-4, 2020.
Register now... |
Conference: Gene Therapy for Neurological Disorders Summit |
Despite travel restrictions, the need to unite and learn from others to progress the development of successful neurological therapeutics is essential. To facilitate this, Gene Therapy for Neurological Disorders, December 8-10, 2020, is returning for its second year, but this time, using a tried and tested digital platform.
With 26+ expert speakers from likes of Voyager Therapeutics, REGENXBIO, Sarepta and AveXis, this is the only meeting to focus on the translational challenges of developing gene therapies targeting the CNS, and will provide the perfect opportunity to make up for lost networking time with gene therapy industry leaders.
Register now... |
Conference: 3rd RNA-Targeted Drug Discovery Summit |
With numerous approaches emerging to demonstrate genuine viability in directly or indirectly targeting RNA with small molecules, join leading biopharmaceutical directors, VPs and C-level executives at the 3rd RNA- Targeted Drug Discovery Summit, December 8-10, 2020, – your premier industry and translational focused conference dedicated to advancing pioneering RNA biology and drug discovery into a blockbuster RNA targeting small molecule therapeutic approach that improves patient outcomes. Register now... |
Conference: PepTalk 2021 Conference |
While a lot has changed since PepTalk was launched in 2001, our number one goal has always been the same - To serve and unite the biotherapeutics community. As we celebrate our 20th year, we are excited to offer a fully integrated virtual PepTalk 2021 event, January 19-21, 2021, that will continue to serve as a content hub for the latest research and biotherapeutics developments, provide a 1:1 networking platform, offer an interactive exhibit hall, live Q&A sessions, breakout groups, research posters, and so much more. Register now... |
Conference: Global Onco Cell Therapy Summit |
Following the success of our first digital event in July with the likes of Carl June leading the keynote, the Onco Cell Therapy Summit is returning in its most interactive form ever with 20+ panel conversations, townhall meetings, roundtable sessions and coffee break style networking.
The Global Onco Cell Therapy Summit is an online event, January 19th - 21st, 2021, that provides a platform for information sharing to enable the discovery, translation and commercialization of cell therapies in oncology by connecting senior representatives in pharma, biotechs and academia. The summit will address the research, regulatory, logistical and technical challenges that are holding back the field. Register now... |
Conference: Gene Therapy Medical Affairs |
The Gene Therapy Medical Affairs Summit, February, 9-11, 2021, is dedicated to exploring the pivotal internal and external role that Medical Affairs plays in delivering gene therapies to patients. Industry pioneers from leading pharma and biotech companies at various stages of development and commercialization including Novartis Gene Therapy, Orchard Therapeutics & Bluebird Bio will share how to engage effectively with internal clinical and commercial teams as well as external HCPs, regulators and patient advocates to create a cohesive and streamlined launch strategy for complex, high priced gene therapy products and ultimately work to remove both barriers that exist for access to gene therapies. Join this conference to delve into the unique Medical Affairs challenges encountered when working with gene therapies, from adapting to the clinical realities of the rare disease space to handling long-term follow up and post-launch scrutiny, equipping you with the insights required to launch gene therapy products more efficiently and effectively. Register now... |
Conference: RNA Therapeutics 2021 |
SMi is proud to announce the 12th Annual RNA Therapeutics Virtual Conference taking place on February 10-11, 2021. The 2021 conference is set to explore the latest developments in RNA delivery agents and RNA-based therapeutics with the latest case studies on advanced mRNA technologies, oligonucleotide delivery, therapeutic applications and future trends and innovations. Register now... |
Conferences |
- |
17 - 19 November 2020, CRISPR 2.0 summit on Gene Editing, Online event |
- |
30 November - 3 December 2020, 2nd Annual Gene Therapy Analytical Development, Online event |
- |
1 - 3 December 2020, Cellular Immunotherapies for Solid Tumors Digital Summit, Online event |
- |
1 - 3 December 2020, 3rd Neuromuscular Drug Development Summit - Gene Therapies, Online event |
- |
1 - 3 December 2020, 2nd RNA Editing Summit, Online event |
- |
2 - 3 December 2020, Breaking Through: Delivering on the Promise of Gene Therapy - Gairdner Ontario International Symposium, Online event |
- |
3 - 4 December 2020, 4th Annual Genome Editing US Congress, Online event |
- |
8 - 10 December 2020, Gene Therapy for Neurological Disorders Summit, Online event/span> |
- |
19 - 21 January 2021, PepTalk 2021 Conference, Online event |
- |
20 - 21 January 2021, Global Onco Cell Therapy Summit, Online event |
- |
2 - 4 February 2021, Next Generation CAR & T Cell Therapies, Kyoto, Japan |
- |
9 - 11 February 2021, Gene Therapy Medical Affairs Summit, Online event |
- |
10 - 11 February 2021, RNA Therapeutics 2021, Online event |
- |
22 - 25 February 2021, 4th Annual Gene Therapy for Rare Disorders, Boston, MA |
- |
9 - 11 March 2021, 2nd Gene Therapy for Blood Disorders meeting, Online event |
- |
15 - 17 March 2021, International Society for BioProcess Technology 10th Spring Meeting - Viral vectors and vaccines, Norfolk, Virginia |
- |
14 - 16 April 2021, World Smart Bioprocessing: Pharma 4.0 Summit, Berlin, Germany |
- |
12 - 15 May 2021, American Society of Gene and Cell Therapy (ASGCT) 24th Annual Meeting, Portland, OR |
- |
14 - 18 June 2021, 9th International Symposium on Monolith - DNA/RNA, vaccines, gene therapy vectors, Portoroz, Slovenia |
- |
31 August - 2 September 2021, CAR-TCR Summit USA, Boston, MA |
- |
22 - 23 September 2021, Oligonucleotide Therapeutics and Delivery conference, London, UK |
- |
12 - 13 October 2021, Pharma Europe 2021 - Cell & Gene Therapies, Barcelona, Spain |
- |
18 - 20 October 2021, Advancing Gene Therapy 2021, Boston, MA |
- |
22 - 23 November 2021, Ophthalmic Drugs Conference - Gene Therapies, London, UK |
|
Read more... |
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net, Zika Virus Net and Corona Virus Net.
|
To unsubscribe from the Newsletter, please login and edit your subscription details, or {unsubscribe}unsubscribe direct{/unsubscribe}, or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}. |
|